AcquisitionOther

InMed Pharmaceuticals Inc. acquired target

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

InMed Pharmaceuticals Inc. -> target · $290.0 million

The unaudited pro forma condensed combined statements of operations for the six months ended June 30, 2026 for InMed and Mentari and for the year ended December 31, 2025 for InMed and Mentari, combine the historical results of InMed and Mentari for those perio

Open source record (SEC) ↗

Have a question, or want to talk something through?

Let's Talk